1. Home
  2. PROV vs ANEB Comparison

PROV vs ANEB Comparison

Compare PROV & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$15.38

Market Cap

98.1M

Sector

Finance

ML Signal

N/A

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$2.38

Market Cap

96.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
ANEB
Founded
1956
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.1M
96.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
PROV
ANEB
Price
$15.38
$2.38
Analyst Decision
Hold
Hold
Analyst Count
2
1
Target Price
$16.25
N/A
AVG Volume (30 Days)
5.9K
17.0K
Earning Date
10-28-2025
11-13-2025
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$39,823,000.00
N/A
Revenue This Year
$4.14
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
$17.06
N/A
Revenue Growth
0.07
N/A
52 Week Low
$12.98
$0.80
52 Week High
$16.70
$3.42

Technical Indicators

Market Signals
Indicator
PROV
ANEB
Relative Strength Index (RSI) 47.02 39.70
Support Level $15.01 $2.26
Resistance Level $15.65 $2.41
Average True Range (ATR) 0.41 0.10
MACD 0.03 -0.00
Stochastic Oscillator 34.07 17.86

Price Performance

Historical Comparison
PROV
ANEB

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: